FundedIQ
Biotechnology

Cour Pharmaceuticals Development: Funding & Investors (Sep 2026)

Cour Pharmaceuticals Development Co Inc operates in the pharmaceutical sector. Cour Pharmaceuticals Development Co Inc was founded in 2012 and is based in Elmhurst, Illinois.

courpharma.com LinkedIn Skokie, United States 51-100 employees
Biotechnology Pharmaceutical Therapeutics
Total raised
$50.0M
Rounds
1
Latest
Series B
Jun 2026

Cour Pharmaceuticals Development has raised $50.0M across 1 funding round on record, the most recent a Series B of $50.0M announced in Jun 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Cour Pharmaceuticals Development Company Profile and Key Stats

Total funding raised
$50.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$50.0M in Jun 2026
Employees
51-100
reported band
Headquarters
Skokie, United States

Latest funding round on record: Jun 2026.

Cour Pharmaceuticals Development Funding Rounds

Date
Round
Amount
Series B
$50.0M

Cour Pharmaceuticals Development Founders and Leadership Team

Name
Role
Contact
John J
Founder

No contact details are on record for this team yet.

Cour Pharmaceuticals Development Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
4,289
$30M

Cour Pharmaceuticals Development's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Cour Pharmaceuticals Development in Biotechnology and Skokie

Companies Similar to Cour Pharmaceuticals Development

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Cour Pharmaceuticals Development Funding FAQs

What does Cour Pharmaceuticals Development do?

Cour Pharmaceuticals Development Co Inc operates in the pharmaceutical sector. Cour Pharmaceuticals Development Co Inc was founded in 2012 and is based in Elmhurst, Illinois.

How much funding has Cour Pharmaceuticals Development raised?

Cour Pharmaceuticals Development has raised $50.0M across 1 round on record. The most recent is a Series B of $50.0M announced in Jun 2026.

When did Cour Pharmaceuticals Development last raise funding?

Cour Pharmaceuticals Development's most recent funding round on record is a Series B of $50.0M, announced in Jun 2026.

Who founded Cour Pharmaceuticals Development?

FundedIQ lists John J (Founder) at Cour Pharmaceuticals Development.

Where is Cour Pharmaceuticals Development headquartered?

Cour Pharmaceuticals Development is based in Skokie, Illinois, United States.

How many employees does Cour Pharmaceuticals Development have?

Cour Pharmaceuticals Development is in the 51-100 employee band.

How does Cour Pharmaceuticals Development's funding compare to other Biotechnology startups?

Cour Pharmaceuticals Development's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Cour Pharmaceuticals Development Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cour Pharmaceuticals Development is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.